RNA‐sequencing analyses revealed the anti‐SCLC mechanisms of these natural compounds and further identified a list of new cellular factors (especially BCAT1) required for SCLC cell survival with clinical implication in SCLC patients. The gene discussed is BCAT1; the disease is small cell lung carcinoma.